Skip to main content

Pure Harvest Corporate Group, Inc. (PHCG)

OTC Markets (US) Healthcare Drug Manufacturers - Specialty & GenericView data quality →
33.1Poor

ValueMarkers Composite Index

Top 1%#44,406 of 44,722

DCF data not available

Piotroski
2/9
Weak
Beneish
-
Altman
-18340.26
Distress
DCF Value
-
N/A
ROIC
4.7%
Low
P/E
0.4
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Pure Harvest Corporate Group, Inc. (PHCG) — VMCI valuation read

Pure Harvest Corporate Group, Inc. (PHCG) carries a VMCI composite of 33/100, 17 points below the Healthcare sector median of 50. Among mid-cap names, that gap places PHCG in the bottom third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The PHCG insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads PHCG trades at 14.0x earnings, 22% below the Healthcare median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Healthcare 12.0x. Quality: ROIC of 14.0% sits 4.0pp above the Healthcare median (10.0%). Risk: net debt to EBITDA of 2.9x is the rate-sensitivity line to watch, the line to track on Pure Harvest Corporate Group, Inc.'s next 10-Q.

PHCG fell 0.3% over the trailing 7 days, with a -22.0% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.